Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine

Michael P. Johnson, Xuemei Huang, Robert Oberlender, J. Frank Nash, David E. Nichols

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The present set of experiments was designed to examine the effects of extension of the α-methyl of p-chloro-amphetamine (PCA) to an α-ethyl. Therefore, the α-ethyl homologue of PCA. l-(4-chlorophenyl)-2-aminobutane (CAB), was compared to PCA in a number of pharmacological assays. CAB was 2-fold less potent than PCA at inhibiting synaptosomal uptake of [3H]5-hydroxytryptamine ([3H]5-HT), and 5-fold less potent at inhibiting uptake of [3H]dopamine ([3H]DA). In drug discrimination assays, CAB was approximately 3-fold less potent than PCA in animals trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or its α-ethyl homologue, S-(+)-N-methyl-1-(l,3-benzodioxol-5-yl)-2-butanamine (S-(+)-MBDB), from saline. Monitoring with in vivo microdialysis, 10 mg/kg of PCA caused a large increase in extracellular DA and a significant decrease in 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In contrast, 11 mg/kg CAB caused no increase and 22 mg/kg CAB caused only a slight increase in extracellular DA. Both doses of CAB caused a decrease in extracellular DOPAC. The potential 5-HT neurotoxicity of CAB was examined by measuring monoamine and metabolite levels and [3H]paroxetine binding at one week following acute doses. A 10 mg/kg dose of PCA caused an 80% decrease in cortical and hippocampal serotonergic markers, while an equimolar dose of CAB decreased only hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels. However, 22 mg/kg of CAB produced a 20-40% decrease in all serotonergic markers. Thus, extension of the α-alkyl significantly decreases the dopaminergic effects of PCA. The similar decrease in relative 5-HT neurotoxicity and the decreased ability to alter dopaminergic systems in vivo and in vitro supports the involvement of DA in the neurotoxicity of PCA.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalEuropean Journal of Pharmacology
Volume191
Issue number1
DOIs
StatePublished - Nov 20 1990

Fingerprint

p-Chloroamphetamine
Amphetamine
Serotonin
N-Methyl-3,4-methylenedioxyamphetamine
3,4-Dihydroxyphenylacetic Acid
Paroxetine
Dopamine Agents
Hydroxyindoleacetic Acid
Microdialysis
Dopamine
Pharmacology

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Johnson, Michael P. ; Huang, Xuemei ; Oberlender, Robert ; Nash, J. Frank ; Nichols, David E. / Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine. In: European Journal of Pharmacology. 1990 ; Vol. 191, No. 1. pp. 1-10.
@article{31d0e8cf88e84200a788b16c34bd8cb3,
title = "Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine",
abstract = "The present set of experiments was designed to examine the effects of extension of the α-methyl of p-chloro-amphetamine (PCA) to an α-ethyl. Therefore, the α-ethyl homologue of PCA. l-(4-chlorophenyl)-2-aminobutane (CAB), was compared to PCA in a number of pharmacological assays. CAB was 2-fold less potent than PCA at inhibiting synaptosomal uptake of [3H]5-hydroxytryptamine ([3H]5-HT), and 5-fold less potent at inhibiting uptake of [3H]dopamine ([3H]DA). In drug discrimination assays, CAB was approximately 3-fold less potent than PCA in animals trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or its α-ethyl homologue, S-(+)-N-methyl-1-(l,3-benzodioxol-5-yl)-2-butanamine (S-(+)-MBDB), from saline. Monitoring with in vivo microdialysis, 10 mg/kg of PCA caused a large increase in extracellular DA and a significant decrease in 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In contrast, 11 mg/kg CAB caused no increase and 22 mg/kg CAB caused only a slight increase in extracellular DA. Both doses of CAB caused a decrease in extracellular DOPAC. The potential 5-HT neurotoxicity of CAB was examined by measuring monoamine and metabolite levels and [3H]paroxetine binding at one week following acute doses. A 10 mg/kg dose of PCA caused an 80{\%} decrease in cortical and hippocampal serotonergic markers, while an equimolar dose of CAB decreased only hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels. However, 22 mg/kg of CAB produced a 20-40{\%} decrease in all serotonergic markers. Thus, extension of the α-alkyl significantly decreases the dopaminergic effects of PCA. The similar decrease in relative 5-HT neurotoxicity and the decreased ability to alter dopaminergic systems in vivo and in vitro supports the involvement of DA in the neurotoxicity of PCA.",
author = "Johnson, {Michael P.} and Xuemei Huang and Robert Oberlender and Nash, {J. Frank} and Nichols, {David E.}",
year = "1990",
month = "11",
day = "20",
doi = "10.1016/0014-2999(90)94090-K",
language = "English (US)",
volume = "191",
pages = "1--10",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine. / Johnson, Michael P.; Huang, Xuemei; Oberlender, Robert; Nash, J. Frank; Nichols, David E.

In: European Journal of Pharmacology, Vol. 191, No. 1, 20.11.1990, p. 1-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine

AU - Johnson, Michael P.

AU - Huang, Xuemei

AU - Oberlender, Robert

AU - Nash, J. Frank

AU - Nichols, David E.

PY - 1990/11/20

Y1 - 1990/11/20

N2 - The present set of experiments was designed to examine the effects of extension of the α-methyl of p-chloro-amphetamine (PCA) to an α-ethyl. Therefore, the α-ethyl homologue of PCA. l-(4-chlorophenyl)-2-aminobutane (CAB), was compared to PCA in a number of pharmacological assays. CAB was 2-fold less potent than PCA at inhibiting synaptosomal uptake of [3H]5-hydroxytryptamine ([3H]5-HT), and 5-fold less potent at inhibiting uptake of [3H]dopamine ([3H]DA). In drug discrimination assays, CAB was approximately 3-fold less potent than PCA in animals trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or its α-ethyl homologue, S-(+)-N-methyl-1-(l,3-benzodioxol-5-yl)-2-butanamine (S-(+)-MBDB), from saline. Monitoring with in vivo microdialysis, 10 mg/kg of PCA caused a large increase in extracellular DA and a significant decrease in 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In contrast, 11 mg/kg CAB caused no increase and 22 mg/kg CAB caused only a slight increase in extracellular DA. Both doses of CAB caused a decrease in extracellular DOPAC. The potential 5-HT neurotoxicity of CAB was examined by measuring monoamine and metabolite levels and [3H]paroxetine binding at one week following acute doses. A 10 mg/kg dose of PCA caused an 80% decrease in cortical and hippocampal serotonergic markers, while an equimolar dose of CAB decreased only hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels. However, 22 mg/kg of CAB produced a 20-40% decrease in all serotonergic markers. Thus, extension of the α-alkyl significantly decreases the dopaminergic effects of PCA. The similar decrease in relative 5-HT neurotoxicity and the decreased ability to alter dopaminergic systems in vivo and in vitro supports the involvement of DA in the neurotoxicity of PCA.

AB - The present set of experiments was designed to examine the effects of extension of the α-methyl of p-chloro-amphetamine (PCA) to an α-ethyl. Therefore, the α-ethyl homologue of PCA. l-(4-chlorophenyl)-2-aminobutane (CAB), was compared to PCA in a number of pharmacological assays. CAB was 2-fold less potent than PCA at inhibiting synaptosomal uptake of [3H]5-hydroxytryptamine ([3H]5-HT), and 5-fold less potent at inhibiting uptake of [3H]dopamine ([3H]DA). In drug discrimination assays, CAB was approximately 3-fold less potent than PCA in animals trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or its α-ethyl homologue, S-(+)-N-methyl-1-(l,3-benzodioxol-5-yl)-2-butanamine (S-(+)-MBDB), from saline. Monitoring with in vivo microdialysis, 10 mg/kg of PCA caused a large increase in extracellular DA and a significant decrease in 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In contrast, 11 mg/kg CAB caused no increase and 22 mg/kg CAB caused only a slight increase in extracellular DA. Both doses of CAB caused a decrease in extracellular DOPAC. The potential 5-HT neurotoxicity of CAB was examined by measuring monoamine and metabolite levels and [3H]paroxetine binding at one week following acute doses. A 10 mg/kg dose of PCA caused an 80% decrease in cortical and hippocampal serotonergic markers, while an equimolar dose of CAB decreased only hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels. However, 22 mg/kg of CAB produced a 20-40% decrease in all serotonergic markers. Thus, extension of the α-alkyl significantly decreases the dopaminergic effects of PCA. The similar decrease in relative 5-HT neurotoxicity and the decreased ability to alter dopaminergic systems in vivo and in vitro supports the involvement of DA in the neurotoxicity of PCA.

UR - http://www.scopus.com/inward/record.url?scp=0025092569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025092569&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(90)94090-K

DO - 10.1016/0014-2999(90)94090-K

M3 - Article

C2 - 1982656

AN - SCOPUS:0025092569

VL - 191

SP - 1

EP - 10

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -